Incisional Biopsy Versus Core-needle Biopsy in Bone Tumors Analysis
Active, not recruiting
- Conditions
- Malignant Bone Tumor
- Registration Number
- NCT07113301
- Lead Sponsor
- Istituto Ortopedico Rizzoli
- Brief Summary
The investigators will collect data of patients with high suspicion of malignant bone tumor based on radiological imaging who underwent/will undergo both core needle biopsy and incisional biopsy for diagnostic confirmation by histological examination.
From 01/01/2015 to the approval date of this study: retrospective study; from the approval date of this study to 31/12/2027: prospective study. the investigators expect to collect data from a total of 72 patients: approximately 30 patients for the retrospective study and 42 for the prospective study. A review will be made from the medical records, radiological imaging, and histological data of partecipants.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
- Age ≥ 2 years
- Patients with high suspicion of malignant bone tumor who underwent/will undergo both core needle biopsy and incisional biopsy
- Male and female patients treated at Rizzoli Orthopaedic Institute from the approval date of this study to 31/12/2027
- Patients with available clinical and imaging data
Exclusion Criteria
- Patients with bone tumor who underwent/will undergo only core needle biopsy
- Patients with bone tumor who underwent/ will undergo only incisional biopsy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method compare the agreement between core needle biopsy and incisional biopsy, based on Cohen's kappa coefficient. through study completion, an average of 3 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Irccs Istituto Ortopedico Rizzoli
🇮🇹Bologna, Emilia-Romagna, Italy
Irccs Istituto Ortopedico Rizzoli🇮🇹Bologna, Emilia-Romagna, Italy